NSECertificate under SEBI (Depositories and Participants) Regulations, 20187 Jul 2026 · 7 Jul 2026, 06:19 pm

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Emcure Pharmaceuticals Limited · EMCURE

✦ AI Summary

Emcure Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018. The company has received a Confirmation Certificate from MUFG Intime India Private Limited, the Registrar and Share Transfer Agent (RTA) of the Company, for the quarter ended June 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Emcure Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Attachments (1)

📄

EMCURE_07072026181912_IntimationReg74_5_ofDPRegulation.pdf

pdf

Download →
View document text
Emcure Ref: EPL/CS/SE/0055/2026 Date: July 07, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, P J Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400 051 Mumbai- 400 001 Script Symbol: EMCURE Scrip Code/Symbol: 544210/ EMCURE Dear Sir/Madam, Subject: Confirmation under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026 Please find enclosed herewith a Confirmation Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026, received from MUFG Intime India Private Limited, the Registrar and Share Transfer Agent (RTA) of the Company. You are requested to take the same on your records. Thanking you, For Emcure Pharmaceuticals Limited Amruta Yangalwar Company Secretary and Compliance Officer ICSI Membership No: A25687 Encl.: As above Emcure Pharmaceuticals Limited Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060 E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251 MUFG Intime India Private Limited (Formerly Link Intime India Private Limited) CIN: U67190MH1999PTC118368 Block No 202, 2nd Floor, Akshay Complex, Off Dhole Patil Road, Pune - 411001 Tel : +91 20 26161629 Website: https://in.mpms.mufg.com SEBI Registration no.: INR000004058 Date: April 06, 2026 Emcure Pharmaceuticals Limited Plot No. P-1 and P-2. IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Pune 411057 Maharashtra, India Subject: Confirmation Certificate in the matter of Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. Dear Sir / Madam, In reference to the above captioned regulation, we hereby confirm that the securities received from the depository participants for dematerialisation during the quarter ended 31st March 2026, were confirmed (accepted/rejected) to the depositories by us and that securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are listed. We hereby also confirm that the security certificates received for dematerialisation have been confirmed/rejected and the security certificates received were mutilated and cancelled after due verification by the depository participant and the name of the depositories have been substituted in the register of members as the registered owner within the prescribed timelines. We request you to kindly take note of the above in your records. Thanking You, Yours faithfully, For MUFG Intime India Private Limited (Formerly known as Link Intime India Private Limited) Ashok Shetty Vice President – Corporate Registry Part of MUFG Pension & Market Services C-101, Embassy 247, L. B. S. Marg, Vikhroli (West), Mumbai - 400 083. Tel. : +91 22 4918 6000.